Page breadcrumb nav

VAERS Report 2157386

Case Report Section

Détails du rapport Vaer

Âge: N/A

Genre: Male

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (PFIZER-BIONTECH))

Type : Coronavirus 2019 vaccine

Fabricant: PFIZER

Lot: unknown


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
2022-01-28
Date d’apparition
8
Nombre de jours (date d’apparition – date de vaccination)
8
Description de l’événement indésirable

guillain-barre syndrome; this is a spontaneous report received from a contactable reporter (physician) from the regulatory authority-web. regulatory number: it-minisal02-844182. a 41 year-old male patient received bnt162b2 (comirnaty), administration date 28jan2022 (lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. relevant medical history included: "immunodeficiency" (unknown if ongoing); "hiv" (unspecified if ongoing). concomitant medication included: dovato. vaccination history included: covid-19 vaccine (dose 1, manufacturer unknown), for covid-19 immunisation; covid-19 vaccine (dose 2, manufacturer unknown), for covid-19 immunisation. the following information was reported: guillain-barre syndrome (life threatening) with onset 05feb2022, outcome "not recovered", described as "guillain-barre syndrome". the patient underwent the following laboratory tests and procedures: cerebro spinal fluid: (05feb2022) dissociation albumino-cytological. therapeutic measures were taken as a result of guillain-barre syndrome which included igev therapy (still in progress). clinical course details: onset of dysesthesia in the 4 limbs, subsequent motor impairment with ataxia of walking. at the test performed diagnosis of guillain-barre syndrome (dissociation albumino-cytological in cerebro spinal fluid). sender's comments: 16feb2022 local regulatory authority: asked to follow up on: vaccine lot number, medications taken by the patient due to hiv immunodeficiency. no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected

Données de laboratoire
test date: 20220205; test name: cerebro spinal fluid; result unstructured data: test result:dissociation albumino-cytological
Liste des symptômes
csf test guillain-barre syndrome
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Other
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na